Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis. (Record no. 28372884)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02284 a2200685 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517214359.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201909s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1532-2742 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.jinf.2018.04.001 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Sanai, Faisal M |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190916 |
| 245 00 - TITLE STATEMENT | |
| Title | Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Journal of infection |
| Date of publication, distribution, etc. | 06 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 536-542 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Observational Study |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antiviral Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzimidazoles |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cohort Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fluorenes |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepacivirus |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis C, Chronic |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Liver Cirrhosis |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ribavirin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sofosbuvir |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sustained Virologic Response |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Uridine Monophosphate |
| General subdivision | administration & dosage |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Altraif, Ibrahim H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alswat, Khalid |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | AlZanbagi, Adnan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Babatin, Mohamed A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | AlMousa, Abdallah |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Almutairi, Nawaf H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aljawad, Mohammed S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alghamdi, Abdullah S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aljumah, Abdulrahman A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alalwan, Abduljaleel M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Al-Hamoudi, Waleed K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Assiri, Abdullah M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dahlan, Yaser |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alsahafi, Ashwaq |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alothmani, Hammad S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | AlSaleemi, Mohammed S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mousa, Waleed A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Albenmousa, Ali |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Awny, Abdelrahman |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Albiladi, Haziz |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Abdo, Ayman A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | AlGhamdi, Hamdan |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Journal of infection |
| Related parts | vol. 76 |
| -- | no. 6 |
| -- | p. 536-542 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.jinf.2018.04.001">https://doi.org/10.1016/j.jinf.2018.04.001</a> |
| Public note | Available from publisher's website |
No items available.